Extending the Value Story Through Real-World Evidence
Pre-approval and post-marketing research has always been supported by regulatory authorities, and has expanded over time to include other interested stakeholders (health insurers, health technology assessment authorities, advocacy groups and provider associations) along with the patients, caregivers, and providers themselves. They all find the real-world performance of therapies and products informative and influential. Real-world data can have a powerful impact on your marketing and development strategy post-approval.
Our integrated, academically grounded primary data collection and medical and scientific communication solutions maximize impact for your business. The breadth of our methodological expertise and deep therapeutic knowledge coupled with expert facilitation and project management ensures protocols and communications are robustly designed and efficiently executed. We deliver robust co-created, evidence generation to internal and external communication solutions.
How we support you
We explore various questions on behalf of our Real-World Evidence clients. Most often, we explore and evidence:
- Identifying real-world patterns of disease progression, diagnosis and treatment (including barriers to use, adherence, safety)
- Understanding outcomes from the perspective of patients, physicians, and caregivers to elevate gaps in care
- Assessing patient and provider preference through discrete choice experiments, utility studies to inform medical communications strategy
- Raising unmet clinical and humanistic needs about burden of disease and therapy through to patient-reported outcomes
